IP
Inovio Pharmaceuticals Inc
🇺🇸XNAS.INOUnited StatesHealthcare
$1.18USDunchanged 0.00 (0%)ClosedEnd of day9:49 PM
Price$1.180.00 (0%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US45773H4092
- CUSIP
- 371916305
Company
- Employees
- 112
- Headquarters
- Plymouth Meeting, United States
- Website
- https://www.inovio.com
- CEO
- Dr. Jacqueline E. Shea Ph.D.
Market
- Shares outstanding
- 103.4M
- Market cap
- $122.01M
Key dates
- Next earnings
- Nov 9, 2026
Highlights
- Market cap
- $122.01M
- EPS LTM
- -$0.65calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- -1.81calculatedCalculated by Finzer, not reported by the data provider.
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- -$65.34K-135.84%down year on year
- Net income
- -$67.43M+23.17%up year on year
- Gross margin
- 3,542.1%+407.4%up year on year
- Free cash flow
- -$80.78M+46.78%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.